The University of Toledo
Website : http://www.utoledo.edu/med/depts/micro

Company Information
In 2006, the Medical University of Ohio (MUO) merged with The University of Toledo (UT) to form the third largest public institution of higher education in Ohio with 23,000 students, 8,000 employees, a $650 million budget, and an estimated economic impact of >$1 billion. The Department of Medical Microbiology & Immunology, chaired by Akira Takashima, M.D., Ph.D., is home to 12 primary faculty and 8 secondary faculty members. Research interests are diverse and multidisciplinary, including bacteriology, virology, parasitology, immunology and transplantation. For candidates interested in translational or clinical research, there is substantial potential for collaborative work with clinicians from other departments, the UT College of Pharmacy, and the UT hospital. In addition to biomedical research at the Health Science Campus, there is potential for collaboration with basic research faculty from the UT Main Campus. Toledo is within driving distance of other academic and medical institutions including the University of Michigan (Ann Arbor – 45 minutes), Michigan State University (East Lansing – 2 hours), Wayne State University (Detroit – 1 hour), and Case Western Reserve University/Cleveland Clinic (Cleveland – 2 hours).

State-of-the-art core facilities available within the department include: tissue culture facility, flow cytometry core, BSL-2 (limited access to a BSL-3 lab also is available), microscopy core, and genomics & proteomic core. University core facilities include the Advanced Microscopy and Imaging Center, Flow Cytometry Core, Center for Drug Design and Development, Instrumentation Center, Nuclear Magnetic Resonance Facility, Center for Materials and Sensor Characterization, and an AAALAC-accredited Animal Care Facility.
Dr. Takashima has recently established the Ohio Center for Innovative Immunosuppressive Therapeutics (OCIIT) by coordinating collaborative efforts among more than 20 scientists and physicians who share interests in the development of new assay platforms, biomarkers, and therapeutics for immunological diseases. The OCIIT program is currently supported by the Third Frontier Program of the state of Ohio ($3 million total funding). Development of HTP screening platforms is one of the central themes of the OCIIT R&D program.

Graduate students are recruited to the Department through the Infection, Immunity and Transplantation (IIT) track of the UT Biomedical Sciences Graduate Program, which supports students’ tuition, the entire stipend during year 1, and a percentage of the stipend during years 2-4. Whereas junior faculty will be protected from heavy teaching loads, faculty members are expected to teach graduate and medical school lectures. Information about the UT graduate program can be found at http://www.utoledo.edu/med/grad/biomedical/iit/index.html. The Department organizes the Immunity and Infection course for second year medical students. With more than 20 faculty contributing to this semester-long course, lecture topics vary based upon faculty expertise. Other opportunities for teaching medical students include Clinical Decision Making and several electives. Departmental faculty also have opportunities to be involved in a number of summer research programs, including SURF (for undergrads) and IMAGINE (for teachers). The percentage of effort devoted to teaching and training activities may vary depending on funding level and seniority.